Serge Verreault - Net Worth and Insider Trading
Serge Verreault Net Worth
The estimated net worth of Serge Verreault is at least $186 dollars as of 2024-09-21. Serge Verreault is the Senior Officer of Crescita Therapeutics Inc and owns about 300 shares of Crescita Therapeutics Inc (TSX:CTX) stock worth over $186. Details can be seen in Serge Verreault's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Serge Verreault has not made any transactions after 2021-12-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Serge Verreault
Serge Verreault Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Serge Verreault owns 1 companies in total, including Crescita Therapeutics Inc (TSX:CTX) .
Click here to see the complete history of Serge Verreault’s form 4 insider trades.
Insider Ownership Summary of Serge Verreault
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:CTX | Crescita Therapeutics Inc | 2021-12-15 | Senior Officer |
Serge Verreault Latest Holdings Summary
Serge Verreault currently owns a total of 1 stock. Serge Verreault owns 300 shares of Crescita Therapeutics Inc (TSX:CTX) as of December 15, 2021, with a value of $186.
Latest Holdings of Serge Verreault
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:CTX | Crescita Therapeutics Inc | 2021-12-15 | 300 | 0.62 | 186 |
Holding Weightings of Serge Verreault
Serge Verreault Form 4 Trading Tracker
According to the SEC Form 4 filings, Serge Verreault has made a total of 6 transactions in Crescita Therapeutics Inc (TSX:CTX) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Crescita Therapeutics Inc is the acquisition of 300 shares on December 15, 2021, which cost Serge Verreault around $195.
Insider Trading History of Serge Verreault
- 1
Serge Verreault Trading Performance
GuruFocus tracks the stock performance after each of Serge Verreault's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Serge Verreault is -10.29%. GuruFocus also compares Serge Verreault's trading performance to market benchmark return within the same time period. The performance of stocks bought by Serge Verreault within 3 months outperforms 0 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Serge Verreault's insider trading performs compared to the benchmark.
Serge Verreault Ownership Network
Serge Verreault Owned Company Details
What does Crescita Therapeutics Inc do?
Who are the key executives at Crescita Therapeutics Inc?
Serge Verreault is the Senior Officer of Crescita Therapeutics Inc. Other key executives at Crescita Therapeutics Inc include Director & Senior Officer Daniel Chicoine , Director & Senior Officer Jose DaRocha , and 10% Security Holder Knight Therapeutics Inc. .
Crescita Therapeutics Inc (TSX:CTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Crescita Therapeutics Inc (TSX:CTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Crescita Therapeutics Inc (TSX:CTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Crescita Therapeutics Inc (TSX:CTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Crescita Therapeutics Inc Insider Transactions
Serge Verreault Mailing Address
Above is the net worth, insider trading, and ownership report for Serge Verreault. Currently GuruFocus does not have mailing address information for Serge Verreault.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
